NHS National Framework for Generic Pharmaceuticals – Wave 15c
Offer reference number: CM/PHG/23/5699
Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
CM/PHG/23/5699/01 Oral (plus non-parenteral) products
CESW/LSNE/NWLN 01/06/2026 to 31/05/2027 (12 months)
CM/PHG/23/5699/02 Hospital only products
DLS: 01/06/2026 to 31/05/2028 (24 months)
DNE: 01/06/2026 to 31/05/2028 (24 months)
CM/PHG/23/5699/03 Hospital only (housekeeping) products
DLN/DNW 01/06/2026 to 31/01/2027 (8 months)
DCE/DSW 01/06/2026 to 30/09/2027 (16 months)